Symbols / XCUR Stock $3.38 +0.90% Exicure, Inc.
XCUR (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
No company description available for this symbol.
Ratings
- Exicure says its cash won't fund the next 12 months of operations - Stock Titan Wed, 25 Mar 2026 07
- Insider Sale: 10% owner at $XCUR Sells 433,332 Shares | XCUR Stock News - Quiver Quantitative hu, 11 Dec 2025 08
- Sangsangin investment sells Exicure (XCUR) shares worth $3.77 million By Investing.com - Investing.com Wed, 10 Dec 2025 08
- Exicure Stock Rockets 70% on Clinical Trials, BlackRock Still In - Gotrade Wed, 31 Dec 2025 08
- New Exicure pact targets Burixafor combos for sickle cell, leukemia - Stock Titan Wed, 22 Apr 2026 23
- Futures Tread Cautiously Pre-Market As Investors Await Key Fed Decision: NVDA, XCUR, GME, CASY Among Stocks To Watch - Stocktwits ue, 09 Dec 2025 11
- What do insiders think about Exicure (XCUR) Stock | Price at $3.81, Up 0.87% - Early Entry - Xã Thanh Hà Mon, 13 Apr 2026 07
- Exicure (XCUR) Stock: Biotech Shares Surge 140% on Cancer Drug Breakthrough - Blockonomi ue, 09 Dec 2025 08
- This BlackRock stock just rocketed 70% - Finbold ue, 09 Dec 2025 08
- Exicure stock soars after positive Phase 2 data for multiple myeloma drug - Investing.com Mon, 08 Dec 2025 08
- symbol__ Stock Quote Price and Forecast - CNN Sun, 10 Dec 2023 05
- Exicure (Nasdaq: XCUR) reports positive Phase 2 burixafor data in multiple myeloma - Stock Titan Mon, 08 Dec 2025 08
- Exicure Stock Soars 40% After Stem Cell Drug Helps Most Patients Hit Phase 2 Goal — Traders Call It ‘Cheap’ At Current Levels - Stocktwits hu, 05 Mar 2026 08
- Is Exicure (XCUR) Stock Gaining Momentum | Price at $3.84, Down 4.24% - High Volume Stocks - Xã Thanh Hà ue, 07 Apr 2026 07
- Phase 2 myeloma stem cell trial: burixafor sees 89.7% hit goal - Stock Titan Wed, 21 Jan 2026 08
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
-100.00%
|
0.50
|
0.00
-100.00%
|
28.83
|
| Operating Revenue |
|
0.00
-100.00%
|
0.50
|
0.00
-100.00%
|
28.83
|
| Operating Expense |
|
10.12
+85.67%
|
5.45
-58.52%
|
13.14
-57.15%
|
30.66
|
| Research And Development |
|
3.29
|
0.00
-100.00%
|
1.42
-92.80%
|
19.77
|
| Selling General And Administration |
|
6.83
+25.36%
|
5.45
-53.49%
|
11.71
+7.58%
|
10.89
|
| General And Administrative Expense |
|
6.83
+25.36%
|
5.45
-53.49%
|
11.71
+7.58%
|
10.89
|
| Other Gand A |
|
6.83
+25.36%
|
5.45
-53.49%
|
11.71
+7.58%
|
10.89
|
| Total Expenses |
|
10.12
+85.67%
|
5.45
-58.52%
|
13.14
-57.15%
|
30.66
|
| Operating Income |
|
-10.12
-104.43%
|
-4.95
+62.33%
|
-13.14
-617.53%
|
-1.83
|
| Total Operating Income As Reported |
|
-4.23
+65.39%
|
-12.23
+18.43%
|
-15.00
-719.01%
|
-1.83
|
| EBITDA |
|
-5.12
+42.16%
|
-8.85
+43.04%
|
-15.54
-20021.79%
|
0.08
|
| Normalized EBITDA |
|
-9.90
-400.15%
|
-1.98
+83.12%
|
-11.73
|
0.00
|
| Reconciled Depreciation |
|
0.46
-44.17%
|
0.82
-40.07%
|
1.38
-25.92%
|
1.86
|
| EBIT |
|
-5.58
+42.34%
|
-9.68
+42.80%
|
-16.91
-851.29%
|
-1.78
|
| Total Unusual Items |
|
4.78
+169.63%
|
-6.87
-80.53%
|
-3.81
-4979.49%
|
0.08
|
| Total Unusual Items Excluding Goodwill |
|
4.78
+169.63%
|
-6.87
-80.53%
|
-3.81
-4979.49%
|
0.08
|
| Special Income Charges |
|
4.68
+168.02%
|
-6.88
-270.08%
|
-1.86
|
0.00
|
| Other Special Charges |
|
-6.32
-647.19%
|
1.16
+23.13%
|
0.94
|
—
|
| Impairment Of Capital Assets |
|
0.00
-100.00%
|
5.72
|
0.00
|
—
|
| Restructuring And Mergern Acquisition |
|
1.55
|
0.00
|
—
|
—
|
| Net Income |
|
-4.95
+49.02%
|
-9.70
+42.65%
|
-16.91
-555.07%
|
-2.58
|
| Pretax Income |
|
-5.58
+42.43%
|
-9.69
+42.69%
|
-16.91
-612.77%
|
-2.37
|
| Net Non Operating Interest Income Expense |
|
0.03
+380.00%
|
-0.01
-131.25%
|
0.03
+105.52%
|
-0.58
|
| Interest Expense Non Operating |
|
0.00
-94.44%
|
0.02
|
0.00
-100.00%
|
0.59
|
| Net Interest Income |
|
0.03
+380.00%
|
-0.01
-131.25%
|
0.03
+105.52%
|
-0.58
|
| Interest Expense |
|
0.00
-94.44%
|
0.02
|
0.00
-100.00%
|
0.59
|
| Interest Income Non Operating |
|
0.03
+262.50%
|
0.01
-75.00%
|
0.03
+113.33%
|
0.01
|
| Interest Income |
|
0.03
+262.50%
|
0.01
-75.00%
|
0.03
+113.33%
|
0.01
|
| Other Income Expense |
|
4.51
+195.25%
|
-4.73
-24.32%
|
-3.81
-10121.05%
|
0.04
|
| Other Non Operating Income Expenses |
|
-0.28
-112.87%
|
2.14
+106950.00%
|
-0.00
+95.00%
|
-0.04
|
| Gain On Sale Of Security |
|
0.11
+2040.00%
|
0.01
+100.26%
|
-1.95
-2597.44%
|
0.08
|
| Tax Provision |
|
-0.63
-8025.00%
|
0.01
|
0.00
-100.00%
|
0.21
|
| Tax Rate For Calcs |
|
0.00
-45.71%
|
0.00
|
0.00
-100.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.55
+137.80%
|
-1.44
|
0.00
-100.00%
|
0.02
|
| Net Income Including Noncontrolling Interests |
|
-4.95
+49.02%
|
-9.70
+42.65%
|
-16.91
-555.07%
|
-2.58
|
| Net Income From Continuing Operation Net Minority Interest |
|
-4.95
+49.02%
|
-9.70
+42.65%
|
-16.91
-555.07%
|
-2.58
|
| Net Income From Continuing And Discontinued Operation |
|
-4.95
+49.02%
|
-9.70
+42.65%
|
-16.91
-555.07%
|
-2.58
|
| Net Income Continuous Operations |
|
-4.95
+49.02%
|
-9.70
+42.65%
|
-16.91
-555.07%
|
-2.58
|
| Normalized Income |
|
-9.18
-114.95%
|
-4.27
+67.40%
|
-13.11
-395.84%
|
-2.64
|
| Net Income Common Stockholders |
|
-4.95
+49.02%
|
-9.70
+42.65%
|
-16.91
-555.07%
|
-2.58
|
| Diluted EPS |
|
-0.79
+83.37%
|
-4.75
+54.98%
|
-10.55
-276.79%
|
-2.80
|
| Basic EPS |
|
-0.79
+83.37%
|
-4.75
+54.98%
|
-10.55
-276.79%
|
-2.80
|
| Basic Average Shares |
|
6.30
+208.19%
|
2.04
+27.48%
|
1.60
+73.48%
|
0.92
|
| Diluted Average Shares |
|
6.30
+208.19%
|
2.04
+27.48%
|
1.60
+73.48%
|
0.92
|
| Diluted NI Availto Com Stockholders |
|
-4.95
+49.02%
|
-9.70
+42.65%
|
-16.91
-555.07%
|
-2.58
|
| Gain On Sale Of PPE |
|
-0.09
|
0.00
+100.00%
|
-0.92
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
14.04
-6.74%
|
15.06
+30.02%
|
11.58
-50.36%
|
23.33
|
| Current Assets |
|
4.62
-66.18%
|
13.67
+575.54%
|
2.02
-79.86%
|
10.05
|
| Cash Cash Equivalents And Short Term Investments |
|
3.75
-70.05%
|
12.51
+1432.84%
|
0.82
-90.49%
|
8.58
|
| Cash And Cash Equivalents |
|
3.75
-70.05%
|
12.51
+1432.84%
|
0.82
-90.49%
|
8.58
|
| Other Short Term Investments |
|
—
|
—
|
—
|
0.00
|
| Receivables |
|
0.06
-89.61%
|
0.56
+123.20%
|
0.25
+125.23%
|
0.11
|
| Accounts Receivable |
|
—
|
—
|
—
|
—
|
| Other Receivables |
|
0.06
-89.61%
|
0.56
+123.20%
|
0.25
+125.23%
|
0.11
|
| Prepaid Assets |
|
0.59
+1.91%
|
0.57
-38.44%
|
0.93
+10.66%
|
0.84
|
| Other Current Assets |
|
0.23
+631.25%
|
0.03
+33.33%
|
0.02
-95.38%
|
0.52
|
| Total Non Current Assets |
|
9.42
+580.91%
|
1.38
-85.53%
|
9.56
-28.03%
|
13.28
|
| Net PPE |
|
0.31
+1076.92%
|
0.03
-99.60%
|
6.57
-32.86%
|
9.79
|
| Gross PPE |
|
0.50
+79.57%
|
0.28
-95.89%
|
6.80
-49.42%
|
13.44
|
| Accumulated Depreciation |
|
-0.20
+22.92%
|
-0.25
-12.44%
|
-0.23
+93.84%
|
-3.65
|
| Properties |
|
0.00
|
0.00
|
—
|
—
|
| Machinery Furniture Equipment |
|
0.06
+72.73%
|
0.03
+0.00%
|
0.03
-64.52%
|
0.09
|
| Construction In Progress |
|
—
|
—
|
—
|
0.00
|
| Other Properties |
|
0.41
+64.63%
|
0.25
-96.36%
|
6.76
-49.32%
|
13.34
|
| Leases |
|
0.04
|
0.00
|
—
|
—
|
| Goodwill And Other Intangible Assets |
|
8.18
|
0.00
|
—
|
—
|
| Goodwill |
|
4.40
|
0.00
|
—
|
—
|
| Other Intangible Assets |
|
3.78
|
—
|
—
|
—
|
| Non Current Prepaid Assets |
|
0.93
-31.61%
|
1.36
-23.98%
|
1.78
-20.74%
|
2.25
|
| Other Non Current Assets |
|
—
|
—
|
1.20
-3.07%
|
1.24
|
| Total Liabilities Net Minority Interest |
|
10.12
+22.10%
|
8.28
-3.10%
|
8.55
+1.70%
|
8.41
|
| Current Liabilities |
|
3.89
+26.60%
|
3.07
+22.35%
|
2.51
+53.14%
|
1.64
|
| Payables And Accrued Expenses |
|
3.71
+58.02%
|
2.35
+24.68%
|
1.88
+71.27%
|
1.10
|
| Payables |
|
1.69
+63.92%
|
1.03
-36.79%
|
1.63
+351.80%
|
0.36
|
| Accounts Payable |
|
1.69
+63.92%
|
1.03
-36.79%
|
1.63
+351.80%
|
0.36
|
| Current Accrued Expenses |
|
2.02
+53.41%
|
1.32
+420.95%
|
0.25
-65.76%
|
0.74
|
| Current Debt And Capital Lease Obligation |
|
0.18
-75.62%
|
0.72
+15.34%
|
0.63
+16.14%
|
0.54
|
| Current Debt |
|
—
|
—
|
—
|
—
|
| Other Current Borrowings |
|
—
|
—
|
—
|
—
|
| Current Capital Lease Obligation |
|
0.18
-75.62%
|
0.72
+15.34%
|
0.63
+16.14%
|
0.54
|
| Current Deferred Liabilities |
|
—
|
—
|
—
|
0.00
|
| Current Deferred Revenue |
|
—
|
—
|
—
|
0.00
|
| Total Non Current Liabilities Net Minority Interest |
|
6.23
+19.45%
|
5.21
-13.68%
|
6.04
-10.76%
|
6.77
|
| Long Term Debt And Capital Lease Obligation |
|
0.00
-100.00%
|
5.21
-13.68%
|
6.04
-10.76%
|
6.77
|
| Long Term Capital Lease Obligation |
|
0.00
-100.00%
|
5.21
-13.68%
|
6.04
-10.76%
|
6.77
|
| Non Current Deferred Liabilities |
|
0.42
|
0.00
|
—
|
0.00
|
| Non Current Deferred Revenue |
|
—
|
—
|
—
|
0.00
|
| Non Current Deferred Taxes Liabilities |
|
0.42
|
0.00
|
—
|
—
|
| Other Non Current Liabilities |
|
5.80
|
—
|
—
|
—
|
| Stockholders Equity |
|
3.93
-42.03%
|
6.77
+123.42%
|
3.03
-79.69%
|
14.92
|
| Common Stock Equity |
|
3.93
-42.03%
|
6.77
+123.42%
|
3.03
-79.69%
|
14.92
|
| Capital Stock |
|
0.00
+0.00%
|
0.00
|
0.00
|
0.00
|
| Common Stock |
|
0.00
+0.00%
|
0.00
|
0.00
|
0.00
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
6.37
+5.76%
|
6.03
+248.34%
|
1.73
+74.20%
|
0.99
|
| Ordinary Shares Number |
|
6.37
+5.76%
|
6.03
+248.34%
|
1.73
+74.20%
|
0.99
|
| Additional Paid In Capital |
|
208.14
+1.02%
|
206.03
+6.98%
|
192.59
+2.68%
|
187.57
|
| Retained Earnings |
|
-204.21
-2.48%
|
-199.26
-5.12%
|
-189.56
-9.80%
|
-172.65
|
| Gains Losses Not Affecting Retained Earnings |
|
-0.00
|
0.00
|
0.00
|
0.00
|
| Other Equity Adjustments |
|
-0.00
|
—
|
—
|
—
|
| Total Equity Gross Minority Interest |
|
3.93
-42.03%
|
6.77
+123.42%
|
3.03
-79.69%
|
14.92
|
| Total Capitalization |
|
3.93
-42.03%
|
6.77
+123.42%
|
3.03
-79.69%
|
14.92
|
| Working Capital |
|
0.74
-93.06%
|
10.60
+2281.48%
|
-0.49
-105.78%
|
8.41
|
| Invested Capital |
|
3.93
-42.03%
|
6.77
+123.42%
|
3.03
-79.69%
|
14.92
|
| Total Debt |
|
0.18
-97.03%
|
5.93
-10.95%
|
6.67
-8.77%
|
7.31
|
| Capital Lease Obligations |
|
0.18
-97.03%
|
5.93
-10.95%
|
6.67
-8.77%
|
7.31
|
| Net Tangible Assets |
|
-4.26
-162.86%
|
6.77
+123.42%
|
3.03
-79.69%
|
14.92
|
| Tangible Book Value |
|
-4.26
-162.86%
|
6.77
+123.42%
|
3.03
-79.69%
|
14.92
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-8.55
-193.99%
|
-2.91
+71.90%
|
-10.36
+70.95%
|
-35.66
|
| Cash Flow From Continuing Operating Activities |
|
-8.55
-193.99%
|
-2.91
+71.90%
|
-10.36
+70.95%
|
-35.66
|
| Net Income From Continuing Operations |
|
-4.95
+49.02%
|
-9.70
+42.65%
|
-16.91
-555.07%
|
-2.58
|
| Depreciation Amortization Depletion |
|
0.46
-44.17%
|
0.82
-40.07%
|
1.38
-25.92%
|
1.86
|
| Depreciation |
|
0.46
-44.17%
|
0.82
-40.07%
|
1.38
-25.92%
|
1.86
|
| Depreciation And Amortization |
|
0.46
-44.17%
|
0.82
-40.07%
|
1.38
-25.92%
|
1.86
|
| Other Non Cash Items |
|
-4.77
-1071.25%
|
-0.41
|
—
|
0.52
|
| Stock Based Compensation |
|
0.00
-90.91%
|
0.02
-98.37%
|
1.35
-1.53%
|
1.37
|
| Asset Impairment Charge |
|
0.00
-100.00%
|
5.72
|
0.00
|
—
|
| Deferred Tax |
|
-0.63
|
0.00
|
—
|
—
|
| Deferred Income Tax |
|
-0.63
|
0.00
|
—
|
—
|
| Operating Gains Losses |
|
0.19
|
—
|
0.92
|
—
|
| Gain Loss On Investment Securities |
|
—
|
—
|
—
|
—
|
| Unrealized Gain Loss On Investment Securities |
|
—
|
0.00
-100.00%
|
2.00
|
0.00
|
| Gain Loss On Sale Of PPE |
|
0.09
|
0.00
-100.00%
|
0.92
|
0.00
|
| Change In Working Capital |
|
1.14
+80.98%
|
0.63
-30.96%
|
0.91
+102.48%
|
-36.81
|
| Change In Receivables |
|
1.34
+365.22%
|
-0.51
|
0.00
|
0.00
|
| Changes In Account Receivables |
|
1.34
+365.22%
|
-0.51
|
0.00
|
0.00
|
| Change In Prepaid Assets |
|
0.04
-96.01%
|
0.98
+33.29%
|
0.73
-75.98%
|
3.05
|
| Change In Payables And Accrued Expense |
|
-0.44
-144.28%
|
0.99
+13.32%
|
0.87
+110.57%
|
-8.24
|
| Change In Accrued Expense |
|
-0.61
-152.03%
|
1.18
+395.74%
|
-0.40
+92.31%
|
-5.19
|
| Change In Payable |
|
0.18
+191.71%
|
-0.19
-115.20%
|
1.27
+141.61%
|
-3.05
|
| Change In Account Payable |
|
0.18
+191.71%
|
-0.19
-115.20%
|
1.27
+141.61%
|
-3.05
|
| Change In Other Working Capital |
|
—
|
—
|
—
|
-28.83
|
| Change In Other Current Assets |
|
0.20
|
0.00
-100.00%
|
0.04
+101.76%
|
-2.17
|
| Change In Other Current Liabilities |
|
0.00
+100.00%
|
-0.83
-13.60%
|
-0.73
-14.29%
|
-0.64
|
| Investing Cash Flow |
|
-1.81
|
0.00
+100.00%
|
-1.08
-122.96%
|
4.70
|
| Cash Flow From Continuing Investing Activities |
|
-1.81
|
0.00
+100.00%
|
-1.08
-122.96%
|
4.70
|
| Net PPE Purchase And Sale |
|
0.04
|
0.00
-100.00%
|
0.92
+349.76%
|
0.20
|
| Sale Of PPE |
|
0.04
|
0.00
-100.00%
|
0.92
+349.76%
|
0.20
|
| Capital Expenditure |
|
-0.00
|
—
|
—
|
-0.01
|
| Capital Expenditure Reported |
|
-0.00
|
0.00
|
0.00
+100.00%
|
-0.01
|
| Net Investment Purchase And Sale |
|
—
|
0.00
+100.00%
|
-2.00
-144.43%
|
4.50
|
| Purchase Of Investment |
|
—
|
0.00
+100.00%
|
-2.00
-33.42%
|
-1.50
|
| Sale Of Investment |
|
—
|
—
|
0.00
-100.00%
|
6.00
|
| Net Business Purchase And Sale |
|
-1.85
|
0.00
|
—
|
—
|
| Purchase Of Business |
|
-2.32
|
0.00
|
—
|
—
|
| Gain Loss On Sale Of Business |
|
0.10
|
0.00
|
—
|
—
|
| Financing Cash Flow |
|
1.60
-88.06%
|
13.40
+264.78%
|
3.67
+218.33%
|
-3.10
|
| Cash Flow From Continuing Financing Activities |
|
1.60
-88.06%
|
13.40
+264.78%
|
3.67
+218.33%
|
-3.10
|
| Net Issuance Payments Of Debt |
|
0.00
-100.00%
|
1.00
|
0.00
+100.00%
|
-7.50
|
| Issuance Of Debt |
|
0.00
-100.00%
|
1.00
|
0.00
|
—
|
| Repayment Of Debt |
|
—
|
—
|
0.00
+100.00%
|
-7.50
|
| Long Term Debt Issuance |
|
—
|
—
|
—
|
—
|
| Long Term Debt Payments |
|
—
|
—
|
0.00
+100.00%
|
-7.50
|
| Net Long Term Debt Issuance |
|
—
|
—
|
0.00
+100.00%
|
-7.50
|
| Short Term Debt Issuance |
|
0.00
-100.00%
|
1.00
|
0.00
|
—
|
| Net Short Term Debt Issuance |
|
0.00
-100.00%
|
1.00
|
0.00
|
—
|
| Net Common Stock Issuance |
|
1.60
-87.10%
|
12.40
+127.98%
|
5.44
+7.94%
|
5.04
|
| Proceeds From Stock Option Exercised |
|
—
|
0.00
+100.00%
|
-0.80
-4310.53%
|
0.02
|
| Net Other Financing Charges |
|
—
|
—
|
-0.97
-45.48%
|
-0.66
|
| Changes In Cash |
|
-8.76
-183.51%
|
10.49
+235.19%
|
-7.76
+77.22%
|
-34.07
|
| Beginning Cash Position |
|
12.51
+520.44%
|
2.02
-79.38%
|
9.78
-77.70%
|
43.84
|
| End Cash Position |
|
3.75
-70.05%
|
12.51
+520.44%
|
2.02
-79.38%
|
9.78
|
| Free Cash Flow |
|
-8.56
-194.02%
|
-2.91
+71.90%
|
-10.36
+70.96%
|
-35.67
|
| Amortization Of Securities |
|
—
|
—
|
0.00
+100.00%
|
-0.00
|
| Common Stock Issuance |
|
1.60
-87.10%
|
12.40
+127.98%
|
5.44
+7.94%
|
5.04
|
| Issuance Of Capital Stock |
|
1.60
-87.10%
|
12.40
+127.98%
|
5.44
+7.94%
|
5.04
|
| Sale Of Business |
|
0.47
|
0.00
|
—
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-10 View
- 8-K2026-04-02 View
- 8-K2026-03-27 View
- 10-K2026-03-25 View
- 8-K2026-03-25 View
- 42026-02-19 View
- 8-K2026-02-17 View
- 8-K2026-02-10 View
- 8-K2026-01-22 View
- 42026-01-21 View
- 42026-01-20 View
- 42026-01-08 View
- 42025-12-10 View
- 42025-11-19 View
- 8-K2025-11-17 View
- 8-K2025-11-10 View
- 10-Q2025-11-07 View
- 8-K2025-11-07 View
- 8-K2025-09-09 View
- 42025-08-20 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|